Platelet activation plays an important role in the pathophysiology of ischemic stroke [36]; increased platelet activation markers (e.g., CD62P, CD63, and CD40L) occurred in both the acute and chronic phase after ischemic stroke [37,38]. The gene discussed is CD63; the disease is ischemic stroke.